These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 27104188
1. Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature. Bommannan K, Sachdeva MU, Malhotra P, Kumar N, Sharma P, Naseem S, Ahluwalia J, Das R, Varma N, Prakash G, Khadwal A, Srinivasan R, Varma S. Blood Res; 2016 Mar; 51(1):23-30. PubMed ID: 27104188 [Abstract] [Full Text] [Related]
4. Plasma Cell Leukemia-Clinicopathological Profile from a Tertiary Care Center in Western India. Manimaran P, Rai V, Ranka R, Sawhney J. South Asian J Cancer; 2023 Jul; 12(3):280-285. PubMed ID: 38047050 [Abstract] [Full Text] [Related]
5. Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study. Wang H, Zhou H, Zhang Z, Geng C, Chen W. Turk J Haematol; 2020 May 06; 37(2):91-97. PubMed ID: 31769277 [Abstract] [Full Text] [Related]
6. The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells. Papadhimitriou SI, Terpos E, Liapis K, Pavlidis D, Marinakis T, Kastritis E, Dimopoulos MA, Tsitsilonis OE, Kostopoulos IV. Biomedicines; 2022 Jan 19; 10(2):. PubMed ID: 35203419 [Abstract] [Full Text] [Related]
9. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature. Gangadhar P, Ahmed Z, Pai MR, Sandhya I. Indian J Pathol Microbiol; 2016 Jan 19; 59(4):541-544. PubMed ID: 27721294 [Abstract] [Full Text] [Related]
12. Genetic profile of primary plasma cell leukemia in Korea: comparison with plasma cell myeloma. Lee Y, Yun J, Jeong D, Ryu S, Kwon SR, Yun H, Kim SM, Park JH, Lee DS. Leuk Lymphoma; 2022 Feb 19; 63(2):385-394. PubMed ID: 34592901 [Abstract] [Full Text] [Related]
15. Acquired del(9)(p22.3) in a primary plasma cell leukemia. Achkar WA, Wafa A, Aljapawe A, Othman MA, Alhourani E, Liehr T. Mol Cytogenet; 2013 Aug 28; 6(1):33. PubMed ID: 23985162 [Abstract] [Full Text] [Related]
17. Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group. Katodritou E, Terpos E, Kelaidi C, Kotsopoulou M, Delimpasi S, Kyrtsonis MC, Symeonidis A, Giannakoulas N, Stefanoudaki A, Christoulas D, Chatziaggelidou C, Gastari V, Spyridis N, Verrou E, Konstantinidou P, Zervas K, Dimopoulos MA. Am J Hematol; 2014 Feb 28; 89(2):145-50. PubMed ID: 24123068 [Abstract] [Full Text] [Related]
18. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome. Todoerti K, Agnelli L, Fabris S, Lionetti M, Tuana G, Mosca L, Lombardi L, Grieco V, Bianchino G, D'Auria F, Statuto T, Mazzoccoli C, De Luca L, Petrucci MT, Morabito F, Offidani M, Di Raimondo F, Falcone A, Omede' P, Tassone P, Boccadoro M, Palumbo A, Neri A, Musto P. Clin Cancer Res; 2013 Jun 15; 19(12):3247-58. PubMed ID: 23599371 [Abstract] [Full Text] [Related]